{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34556735",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "09",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "18985",
      "10.1038/s41598-021-98289-x"
    ],
    "Journal": {
      "ISSN": "2045-2322",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep",
          "Day": "23"
        }
      },
      "Title": "Scientific reports",
      "ISOAbbreviation": "Sci Rep"
    },
    "ArticleTitle": "Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates.",
    "Pagination": {
      "StartPage": "18985",
      "MedlinePgn": "18985"
    },
    "Abstract": {
      "AbstractText": [
        "The COVID-19 pandemic is raging. It revealed the importance of rapid scientific advancement towards understanding and treating new diseases. To address this challenge, we adapt an explainable artificial intelligence algorithm for data fusion and utilize it on new omics data on viral-host interactions, human protein interactions, and drugs to better understand SARS-CoV-2 infection mechanisms and predict new drug-target interactions for COVID-19. We discover that in the human interactome, the human proteins targeted by SARS-CoV-2 proteins and the genes that are differentially expressed after the infection have common neighbors central in the interactome that may be key to the disease mechanisms. We uncover 185 new drug-target interactions targeting 49 of these key genes and suggest re-purposing of 149 FDA-approved drugs, including drugs targeting VEGF and nitric oxide signaling, whose pathways coincide with the observed COVID-19 symptoms. Our integrative methodology is universal and can enable insight into this and other serious diseases."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barcelona Supercomputing Center, Barcelona, Spain."
          }
        ],
        "LastName": "Zambrana",
        "ForeName": "Carme",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barcelona Supercomputing Center, Barcelona, Spain."
          }
        ],
        "LastName": "Xenos",
        "ForeName": "Alexandros",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barcelona Supercomputing Center, Barcelona, Spain."
          }
        ],
        "LastName": "B\u00f6ttcher",
        "ForeName": "Ren\u00e9",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barcelona Supercomputing Center, Barcelona, Spain."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Computer Science, University College London, London, WC1E 6BT, UK."
          }
        ],
        "LastName": "Malod-Dognin",
        "ForeName": "No\u00ebl",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barcelona Supercomputing Center, Barcelona, Spain. natasha@bsc.es."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Computer Science, University College London, London, WC1E 6BT, UK. natasha@bsc.es."
          },
          {
            "Identifier": [],
            "Affiliation": "ICREA, Pg. Llu\u00eds Companys 23, Barcelona, Spain. natasha@bsc.es."
          }
        ],
        "LastName": "Pr\u017eulj",
        "ForeName": "Nata\u0161a",
        "Initials": "N"
      }
    ],
    "GrantList": [
      {
        "GrantID": "770827",
        "Acronym": "ERC_",
        "Agency": "European Research Council",
        "Country": "International"
      },
      {
        "GrantID": "PID2019-105500GB-I00",
        "Agency": "Agencia Estatal de Investigaci\u00f3n",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Sci Rep",
    "NlmUniqueID": "101563288",
    "ISSNLinking": "2045-2322"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pharmaceutical Preparations"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Artificial Intelligence"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Drug Evaluation, Preclinical"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Gene Regulatory Networks"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Theoretical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pharmaceutical Preparations"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}